NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
Ontology highlight
ABSTRACT: The surface inhibitory receptor NKG2A forms heterodimers with the invariant CD94 chain and is expressed on a subset of activated CD8 T cells. As antibodies to block NKG2A are currently tested in several efficacy trials for different tumor indications, it is important to characterize the NKG2A+ CD8 T cell population in the context of other inhibitory receptors. Here we used a well-controlled culture system to study the kinetics of inhibitory receptor expression. Naïve mouse CD8 T cells were synchronously and repeatedly activated by artificial antigen presenting cells in the presence of the homeostatic cytokine IL-7. The results revealed NKG2A as a late inhibitory receptor, expressed after repeated cognate antigen stimulations. In contrast, the expression of PD-1, TIGIT and LAG-3
SUBMITTER: Borst L
PROVIDER: S-EPMC9299709 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA